What's fueling the biotech engine—2009–2010

Who Should Get the HPV Vaccine? Usage Expands Amid Debate

(2010) Judy Peres   JNCI-Journal of the National Cancer Institute

Targeted cancer therapies

(2010) Saurabh Aggarwal   NATURE REVIEWS DRUG DISCOVERY

Nonadherence to Imatinib during an Economic Downturn

(2010) Robin K. Kelley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy

(2010) Mary Parks et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment with Monoclonal Antibodies againstClostridium difficileToxins

(2010) Israel Lowy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

(2010) Jeffrey A. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Erythropoiesis-Stimulating Agents — Time for a Reevaluation

(2010) Ellis F. Unger et al.   NEW ENGLAND JOURNAL OF MEDICINE

What's fueling the biotech engine—2008

(2009) Saurabh Aggarwal   NATURE BIOTECHNOLOGY

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

The 2009 COID Recommendations for RSV Prophylaxis: Issues of Efficacy, Cost, and Evidence-Based Medicine

(2009) L. R. Krilov et al.   PEDIATRICS

What's fueling the biotech engine—2007

(2008) Saurabh Aggarwal   NATURE BIOTECHNOLOGY